文献速递心外重症与机械循环支持

心脏术后体外膜氧合支持期间与撤机后死亡率分析

On-Support and Postweaning Mortality in Postcardiotomy Extracorporeal Membrane Oxygenation.
PubMed 文献 · Ann Thorac Surg · 2023-07-05

这项回顾性多中心观察性研究纳入2000至2020年间2058例心脏术后需静脉-动脉体外膜氧合(VA ECMO)的成人患者,撤机率为62.7%,出院存活率为39.6%。36.6%的患者在ECMO支持期间死亡,多与术前血流动力学不稳定相关;另有23.1%在撤机后死亡,与严重并发症相关。

要点

  • 心脏术后VA ECMO撤机率62.7%,但出院存活率仅39.6%。
  • 36.6%患者在ECMO支持期间死亡,主要死因为多器官衰竭和持续性心力衰竭。
  • 23.1%患者撤机后死亡,脓毒症是撤机后主要死因之一。

核心结论

  • 心脏术后ECMO患者撤机率与出院率之间存在差异。
  • 36.6%的患者在ECMO支持期间死亡,主要与术前血流动力学不稳定相关。
  • 另有23.1%的患者在撤机后死亡,与严重并发症相关,强调撤机后护理的重要性。

研究设计与样本

  • 回顾性、多中心、观察性心脏术后体外生命支持研究(PELS),纳入2000年至2020年间需要心脏术后VA ECMO的成人患者2058例,男性59%,中位年龄65岁(IQR 55-72岁)。

主要发现

  • 撤机率为62.7%,出院存活率为39.6%。
  • 死亡患者共1244例,其中ECMO支持期间死亡754例(36.6%,中位支持时间79小时,IQR 24-192小时),撤机后死亡476例(23.1%,中位支持时间146小时,IQR 96-235.5小时)。
  • 多器官衰竭(431/1158,37.2%)和持续性心力衰竭(423/1158,36.5%)是主要死因;ECMO支持期间死亡者中出血占7.4%(56/754),撤机后死亡者中脓毒症占15.4%(61/401)。
  • ECMO支持期间死亡与急诊手术、术前心脏骤停、心源性休克、右心室衰竭、体外循环时间和ECMO植入时机相关。
  • 撤机后死亡与糖尿病、术后出血、心脏骤停、肠缺血、急性肾损伤和脓毒性休克相关。

临床怎么用

  • 原文强调对心脏术后VA ECMO患者撤机后护理的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postcardiotomy venoarterial extracorporeal membrane oxygenation (VA ECMO) is characterized by discrepancies between weaning and survival-to-discharge rates. This study analyzes the differences between postcardiotomy VA ECMO patients who survived, died on ECMO, or died after ECMO weaning. Causes of death and variables associated with mortality at different time points are investigated. METHODS: The retrospective, multicenter, observational Postcardiotomy Extracorporeal Life Support Study (PELS) includes adults requiring postcardiotomy VA ECMO between 2000 and 2020. Variables associated with on-ECMO mortality and postweaning mortality were modeled using mixed Cox proportional hazards, including random effects for center and year. RESULTS: In 2058 patients (men, 59%; median age, 65 years; interquartile range [IQR], 55-72 years), weaning rate was 62.7%, and survival to discharge was 39.6%. Patients who died (n = 1244) included 754 on-ECMO deaths (36.6%; median support time, 79 hours; IQR, 24-192 hours), and 476 postweaning deaths (23.1%; median support time, 146 hours; IQR, 96-235.5 hours). Multiorgan (n = 431 of 1158 [37.2%]) and persistent heart failure (n = 423 of 1158 [36.5%]) were the main causes of death, followed by bleeding (n = 56 of 754 [7.4%]) for on-ECMO mortality and sepsis (n = 61 of 401 [15.4%]) for postweaning mortality. On-ECMO death was associated with emergency surgery, preoperative cardiac arrest, cardiogenic shock, right ventricular failure, cardiopulmonary bypass time, and ECMO implantation timing. Diabetes, postoperative bleeding, cardiac arrest, bowel ischemia, acute kidney injury, and septic shock were associated with postweaning mortality. CONCLUSIONS: A discrepancy exists between weaning and discharge rate in postcardiotomy ECMO. Deaths occurred during ECMO support in 36.6% of patients, mostly associated with unstable preoperative hemodynamics. Another 23.1% of patients died after weaning in association with severe complications. This underscores the importance of postweaning care for postcardiotomy VA ECMO patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Mariani S, Schaefer AK, van Bussel BCT, et al. On-Support and Postweaning Mortality in Postcardiotomy Extracorporeal Membrane Oxygenation. Ann Thorac Surg. 2023. PMID: 37414384. doi:10.1016/j.athoracsur.2023.05.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。